TED Stock Overview
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
TerrAscend Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$1.51 |
| 52 Week High | CA$2.15 |
| 52 Week Low | CA$1.18 |
| Beta | 1.98 |
| 1 Month Change | -3.21% |
| 3 Month Change | -20.11% |
| 1 Year Change | 2.72% |
| 3 Year Change | -83.13% |
| 5 Year Change | -72.99% |
| Change since IPO | 135.57% |
Recent News & Updates
Recent updates
Shareholder Returns
| TED | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -9.6% | 2.3% | 0.5% |
| 1Y | 2.7% | -28.6% | 1.3% |
Return vs Industry: TED exceeded the German Pharmaceuticals industry which returned -28.2% over the past year.
Return vs Market: TED matched the German Market which returned 2.3% over the past year.
Price Volatility
| TED volatility | |
|---|---|
| TED Average Weekly Movement | 13.4% |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: TED's share price has been volatile over the past 3 months.
Volatility Over Time: TED's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 1,055 | Ziad Ghanem | www.terrascend.com |
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.
TerrAscend Corp. Fundamentals Summary
| TED fundamental statistics | |
|---|---|
| Market cap | €544.65m |
| Earnings (TTM) | -€84.92m |
| Revenue (TTM) | €295.81m |
1.5x
P/S Ratio-5.1x
P/E RatioIs TED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TED income statement (TTM) | |
|---|---|
| Revenue | US$317.33m |
| Cost of Revenue | US$157.63m |
| Gross Profit | US$159.70m |
| Other Expenses | US$250.80m |
| Earnings | -US$91.10m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
| Earnings per share (EPS) | -0.31 |
| Gross Margin | 50.33% |
| Net Profit Margin | -28.71% |
| Debt/Equity Ratio | 85.8% |
How did TED perform over the long term?
See historical performance and comparison